DYNAMIQ IN THE NEWS: EPIPENS RECALLED – AUSTRALIA, NEW ZEALAND, JAPAN AND EUROPE

EpiPen recall

Alphapharm is recalling four batches of EpiPen® 300 microgram (µg) Adrenaline Injection Syringe Auto-Injectors. These devices may contain a defective part which can make the device fail.  

Affected batch numbers are 5FA665, 5FA6651, 5FA6652, 5FA6653.

EpiPen® Auto-Injector is used for the treatment of allergic emergencies (anaphylaxis). The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline resulting in the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life threatening.

Key points

1.  Check if you have a 300 µg EpiPen® (yellow carton and label). If you do, check the batch number and expiry. The batch number and expiry can be found on the label of the pen or on the end of the carton.

2.  If your EpiPen® 300µg has the following batch numbers 5FA665, 5FA6651, 5FA6652 or 5FA6653 and an expiry of Apr 17, you need to replace it with a new one as soon as possible.

3. Keep your current EpiPen® until you get a replacement and use it if required.

First aid training

Now is a good time to book your first aid training for 2017 to ensure your people are ready to face a medical incident in the workplace.

Our first aid course is a full day, and includes national accreditation for CPR, anaphylaxis and asthma. We deliver these courses right across Australia for corporates, schools, resource companies and special interest groups.

Contact us to arrange first aid training.

Back to all news